Phase 2 Psoriasis trials recruiting now

All Psoriasis trials, every phase

Other phases for Psoriasis

Phase 2 Psoriasis trials

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
  NCT07013201 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
  NCT07406035 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 44 locations
• A Phase 2 Study of HB0017 in Psoriasis Patients
  NCT06592274 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations
• A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
  NCT07315061 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
  NCT07233291 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of Picankibart in Patients With Active Psoriatic Arthritis
  NCT07295509 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
  NCT06912165 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
  NCT07801495 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
  NCT07489885 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 20 locations
• A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
  NCT07129382 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
• A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
  NCT07321873 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 73 locations
• Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.
  NCT07410793 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
  NCT07449702 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
  NCT07474792 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 39 locations
• Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
  NCT06742333 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 7 locations
• Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
  NCT06231381 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
  NCT06176508 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
  NCT07251998 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
  NCT06058546 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
  NCT06477536 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
  NCT07719530 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
  NCT07204639 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
  NCT04924270 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
  NCT07194200 · Phase: Phase 2 · Ages: 16 Years to 60 Years · Sex: All (male and female) · 1 location
• Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis
  NCT05815797 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
  NCT06865105 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
  NCT07486960 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 50 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.